Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/10/2025

Near-Fatal Asthma Management

Introduction to Near-Fatal Asthma

  • The British Thoracic Society defines near-fatal asthma by the presence of life-threatening features that demand urgent intervention, including peak expiratory flow (PEF) <33% of predicted or best, silent chest, cyanosis, or feeble respiratory effort, bradycardia or hypotension, exhaustion, confusion, or coma, and severe hypoxia: PaO₂ <8 kPa despite oxygen therapy 1, 3

Life-Threatening Features Requiring Immediate Action

  • Near-fatal asthma is characterized by life-threatening features such as PEF <33% of predicted or best, silent chest, cyanosis, or feeble respiratory effort, bradycardia or hypotension, exhaustion, confusion, or coma, and normal or elevated PaCO₂ (5-6 kPa or higher) in a breathless patient, and severe hypoxia: PaO₂ <8 kPa despite oxygen therapy 1, 3

First-Line Medication Protocol

  • The British Thoracic Society recommends immediate administration of high-dose nebulized beta-agonists (salbutamol 5 mg or terbutaline 10 mg) with oxygen, high-dose systemic corticosteroids (prednisolone 30-60 mg or IV hydrocortisone 200 mg), and add nebulized ipratropium (0.5 mg) plus IV aminophylline (250 mg over 20 minutes) or IV beta-agonist (salbutamol or terbutaline 250 µg over 10 minutes) 1, 2, 3
  • High-dose inhaled beta-agonists should be delivered via oxygen-driven nebulizer (40-60% oxygen) and repeated every 15-30 minutes if no improvement 1, 2, 3, 5, 6
  • High-dose systemic corticosteroids, such as prednisolone 30-60 mg orally or IV hydrocortisone 200 mg, should be administered and continued every 6 hours for seriously ill or vomiting patients 1, 2, 3

Additional Medications for Life-Threatening Features

  • Nebulized ipratropium (0.5 mg) should be added to the beta-agonist nebulizer and repeated every 6 hours until improvement begins 1, 2, 3, 7
  • IV aminophylline (250 mg over 20 minutes) or IV beta-agonist (salbutamol or terbutaline 250 µg over 10 minutes) should be considered for patients with life-threatening features 1, 2, 3, 4

Monitoring and Escalation

  • Patients should be reassessed at 15-30 minutes after initial treatment, and if no improvement, the nebulized beta-agonist frequency should be increased to every 15 minutes 1, 4, 5, 6
  • Arterial blood gases should be measured in all hospitalized patients 1, 3

Intensive Care Indications

  • Patients with deteriorating PEF, worsening or persistent hypoxia (PaO₂ <8 kPa) despite 60% oxygen, or hypercapnia (PaCO₂ >6 kPa) should be transferred to the ICU with a physician prepared to intubate 2, 7

Critical Pitfalls to Avoid

  • Sedation is absolutely contraindicated in near-fatal asthma 1, 2
  • Antibiotics should only be administered if a bacterial infection is confirmed 1, 2
  • Percussive physiotherapy is unnecessary in near-fatal asthma 2
  • Failure to make objective measurements (PEF, arterial blood gases) and underestimation of severity by patients, relatives, and doctors are common errors leading to mortality 1, 3, 5, 6

REFERENCES